215,844 research outputs found
Personal Papers (MS 80-0002)
Letter from I. H. Kempner to Lu-Tex Products, Inc. discussing the lack of reply to his previous inquiry and asking about turkeys to be shipped to him
Personal Papers (MS 80-0002)
Letter from I. H. Kempner to Lu-Tex Products, Inc. discussing turkeys to be shipped to Kempner. Kempner also mentions that the previous turkeys sent were not of usual quality
Lu-H-N phase diagram from first-principles calculations
Using a comprehensive structure search and high-throughput first-principles
calculations of 1483 compounds, this study presents the phase diagram of
Lu-H-N. The formation energy landscape of Lu-H-N was derived and utilized to
assess the thermodynamic stability of compounds. Results indicate that there
are no stable Lu-H-N ternary structures in this system, but metastable ternary
structures, such as Lu20H2N17 (C2/m), Lu2H2N (P3-m1), were observed with small
Ehull (< 100 meV/atom). Moreover, applying hydrostatic pressure up to 10 GPa
causes the energy convex hull of the Lu-H-N to shift its shape and stabilizes
binary phases such as LuN9 and Lu10H21. Additionally, interstitial empty sites
in LuH2 were noted, which may explain the formation of Lu10H21 and LuH3-xNy. To
provide a basis for comparison, X-ray diffraction patterns and electronic
structures of some compounds are also presented
Flaviata Lu & Qin 2014
Flaviata Lu & Qin, 2014 Type species: Flaviata variata Lu & Qin in Qin et al. 2014: 1506, by original designation. For detailed generic diagnosis see Xu et al., 2015. Distribution. Southern China (Sichuan, Zhejiang, Yunnan, Guizhou).Published as part of Xu, Ye, Lu, Sihan, Dietrich, Christopher H. & Qin, Daozheng, 2018, Descriptions of two new leafhopper species of the genus Flaviata Lu & Qin (Hemiptera, Cicadellidae, Typhlocybinae) from Southern China, with a key to known species, pp. 577-582 in Zootaxa 4457 (4) on page 578, DOI: 10.11646/zootaxa.4457.4.7, http://zenodo.org/record/145807
ACA inhibited cell viability of A549 and SK-LU-1 cell lines.
(A) Chemical structure of 1’S-1’-acetoxychavicol acetate (ACA). (B) The cell viability of MCF 10A, A549 and SK-LU-1 cells lines after exposure to ACA (0–30 μM) for 24 h was assessed using MTT assay. Data represented as mean percentage of cell viability ± SD for three independent experiments. (C) The cell viability of A549 and SK-LU-1 cells lines after exposure to IC50 of ACA (25 μM for SK-LU-1 and 30 μM for A549 cells) on respective cell lines for 0–24 h was assessed using MTT assay. Data represented as mean percentage of cell viability ± SD for three independent experiments. * p p < 0.01 statistically different in comparison to 0 h (D) Representative photomicrograph (200 × magnification) of A549 and SK-LU-1 cell lines upon ACA treatment. Arrow indicates the cytoplasmic vacuole.</p
Personal Papers (MS 80-0002)
Letter from I. H. Kempner to Lu-Tex Products, Inc. informing the company that he bought turkeys elsewhere due to the delayed response
Personal Papers (MS 80-0002)
Letter from I. H. Kempner to Lu-Tex Products, Inc. requesting a few turkeys because the ones sold in Galveston are too small for a large family
Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy
Prostate-specific membrane antigen (PSMA) is an excellent
target
for imaging and radionuclide therapy of prostate cancer. Recently,
[177Lu]Lu-PSMA-617 (Pluvicto) was approved by the FDA for
radionuclide therapy. To develop hetero-bivalent agents targeting
both PSMA and bone metastasis, [177Lu]Lu-P17-079 ([177Lu]Lu-1) and [177Lu]Lu-P17-081 ([177Lu]Lu-2) were prepared. In vivo biodistribution studies of [177Lu]Lu-PSMA-617, [177Lu]Lu-1, and [177Lu]Lu-2 in mice bearing PC3-PIP (PSMA positive) tumor showed high
uptake in PSMA-positive tumor (14.5, 14.7, and 11.3% ID/g at 1 h,
respectively) and distinctively different bone uptakes (0.52, 6.52,
and 5.82% ID/g at 1 h, respectively). PET imaging using [68Ga]Ga-P17-079 ([68Ga]Ga-1) in the same mouse model displayed
excellent images confirming the expected dual-targeting to PSMA-positive
tumor and bone. Results suggest that [177Lu]Lu-P17-079
([177Lu]Lu-1) is a promising candidate for further development
as a hetero-bivalent radionuclide therapy agent targeting both PSMA
expression and bone metastases for the treatment of prostate cancer
Haipeng Lu
"The best advice I have ever been given is, 'It is never too early to prepare, and it is never too late to change' horizontal ellipsis My long-term goal is to contribute something actually useful to society horizontal ellipsis " Find out more about Haipeng Lu in his Introducing horizontal ellipsis Profile
Hyphocapnodia Z. H. Lu & Maharachch. 2022, gen. nov.
Hyphocapnodia Z. H. Lu & Maharachch., gen. nov. MycoBank number: MB 845348 Etymology: The name reflects the hyphomycetous morph phylogenetically related to Capnodium Saprobic on living and decaying branches. Sexual morph: not observed. Asexual morph: on the natural substrate, colonies effuse, hairy, black. Mycelium immersed and superficial, forming dark brown conidiomata. Conidiomata synnematous, erect, subcylindrical, dark brown to black, with conidiogenous cells distributed mostly laterally, mainly towards the upper half of the synnemata. Conidiophores macronematous, simple, dark brown. Conidiogenous cells monoblastic, cylindrical, integrated, determinate, and smooth. Conidia subcylindrical to fusiform, brown, transversely septate, conidial secession schizolytic. Type species: Hyphocapnodia sichuanensis Z. H. Lu, Wanas., Madrid & Maharachch., sp. nov.Published as part of Lu, Zheng-Hua, Wanasinghe, Dhanushka N., Madrid, Hugo & Maharachchikumbura, Sajeewa S. N., 2022, Hyphocapnodia sichuanensis gen. et sp. nov. (Capnodiaceae), a novel hyphomycete from Sichuan Province, China, pp. 84-94 in Phytotaxa 564 (1) on page 90, DOI: 10.11646/phytotaxa.564.1.6, http://zenodo.org/record/707786
- …
